Results 141 to 150 of about 112,287,737 (220)

Exceptional Response of HER2-Positive Breast Cancer to Osimertinib: A Case Report. [PDF]

Thorac Cancer
Yasui H, Hatasa M, Ohara K, Sano K, Mori Y, Shibata T, Fukui Y, Odate M, Arai Y, Fujii M, Makino Y.   +10 more
europepmc   +1 more source

Intermittent fasting promotes remodeling of neural and vascular networks in visceral white adipose tissue. [PDF]

iScience
Vo N, Yew A, Zhang Q, Jeong S, Togo J, Park JG, Sung HK.   +6 more
europepmc   +1 more source

ERBB4 and Neurodegeneration: Association Between Hypothalamic-Pituitary-Adrenal (HPA) Axis: Associated Neurodegenerative Pathogenesis. [PDF]

Cells
Bagyinszky E, An SSA.
europepmc   +1 more source

Complete Imaging Resolution of Ductal Carcinoma In Situ During Osimertinib Therapy for Synchronous EGFR Exon 19-Mutant Non-Small Cell Lung Cancer: A Case Report. [PDF]

Int J Mol Sci
Assad Maia Sandoval L, Sharpe RE, Fullenkamp AJ, Downs E, Mina L.   +4 more
europepmc   +1 more source

Differential ErbB receptor dimerization modulates the ability of EGF receptor ligands to regulate metabolic flux. [PDF]

J Biol Chem
Macdonald-Obermann J, Cho K, Patti GJ, Pike LJ.   +3 more
europepmc   +1 more source

c-erbB-2 and human cancer.

Japanese journal of cancer research : Gann, 1993
openaire   +1 more source

An AI-derived peptide PCa2 suppresses pancreatic cancer growth via modulation of the ErbB/PI3K/AKT/mTOR/MYC signaling axis. [PDF]

Cell Commun Signal
Zuo W, Luo S, Qin H, Wong KH, Siu SWI, Tashima AK, Assaraf YG, Kwok HF.   +7 more
europepmc   +1 more source

Cutaneous gain-of-function mutation of LRIG3 leads to alopecia by upregulation of ERBB, PI3K/AKT, NOTCH1 signaling pathways. [PDF]

Sci Rep
Ghorbanalipoor S, Hösl C, Kolbe T, Dahlhoff M.   +3 more
europepmc   +1 more source

High-intensity interval training enhanced cardioprotective effects of neuregulin-1 against doxorubicin-induced cardiotoxicity. [PDF]

Sci Rep
Rezaeinezhad N, Jamali P, Fatholahi K, Afousi AG.   +3 more
europepmc   +1 more source

Maspin Modulates Malignant Phenotypes Depending on Subcellular Localization in Pancreatic Ductal Adenocarcinoma Cell Lines. [PDF]

Cancers (Basel)
Mochida H, Sakabe T, Shingu T, Makishima K, Umekita Y.   +4 more
europepmc   +1 more source